In this model, it was observed that when VSV encoded tumor antigens, virotherapy enhanced antitumor CD8+ T-cell responses, and the combination of ICI and chimeric viruses achieved 100% long-term survival in some experimental groups [93]. Here, CD8A is linked to neoplasm.